Re: “Erythema Annulare Centrifugum due to Pegylated Interferon-α-2a plus Ribavirin Combination Therapy in a Patient with Chronic Hepatitis C Virus Infection”
Restricted accessLetterFirst published online January, 2015
Re: “Erythema Annulare Centrifugum due to Pegylated Interferon-α-2a plus Ribavirin Combination Therapy in a Patient with Chronic Hepatitis C Virus Infection”
GonulMKulcu CakmakSOzcanN. Erythema annulare centrifugum due to pegylated interferon-α-2a plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. J Cutan Med Surg2014;18:65–8.
2.
WeyersWDiaz-CascajoCWeyersI. Erythema annulare centrifugum: results of a clinicopathologic study of 73 patients. Am J Dermatopathol2003;25:451–62, doi:10.1097/00000372-200312000-00001.
3.
NaccaratoMYoongDSolomonRSOstrowskiM. Erythema annulare centrifugum-like eruption associated with pegylated interferon treatment for hepatitis C. Dermatol Rep2013;5:e1, doi:10.4081/dr.2013.e1.
